Cargando…
Drug Repurposing: a Shortcut to New Biological Entities
Drug repurposing has proved to be an efficient alternative to drug discovery owing to the facts that it is economical and risk factors being much lower or even negligible as the drug has already been approved for having safe use in humans. The contrast of drug discovery from drug repurposing, its ad...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734433/ https://www.ncbi.nlm.nih.gov/pubmed/36531825 http://dx.doi.org/10.1007/s11094-022-02778-w |
_version_ | 1784846583764877312 |
---|---|
author | Rao, Nutan Poojari, Tushar Poojary, Charvi Sande, Ruksar Sawant, Sonal |
author_facet | Rao, Nutan Poojari, Tushar Poojary, Charvi Sande, Ruksar Sawant, Sonal |
author_sort | Rao, Nutan |
collection | PubMed |
description | Drug repurposing has proved to be an efficient alternative to drug discovery owing to the facts that it is economical and risk factors being much lower or even negligible as the drug has already been approved for having safe use in humans. The contrast of drug discovery from drug repurposing, its advantages and the challenges faced during the process are the important factors to be considered in drug repurposing. The approaches in drug discovery include three methods namely computational, biological and mixed. Moreover, the recent advancement in application of drugs for COVID-19 proved drug repurposing is a vital strategy in medical science for the upcoming years. |
format | Online Article Text |
id | pubmed-9734433 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-97344332022-12-12 Drug Repurposing: a Shortcut to New Biological Entities Rao, Nutan Poojari, Tushar Poojary, Charvi Sande, Ruksar Sawant, Sonal Pharm Chem J Article Drug repurposing has proved to be an efficient alternative to drug discovery owing to the facts that it is economical and risk factors being much lower or even negligible as the drug has already been approved for having safe use in humans. The contrast of drug discovery from drug repurposing, its advantages and the challenges faced during the process are the important factors to be considered in drug repurposing. The approaches in drug discovery include three methods namely computational, biological and mixed. Moreover, the recent advancement in application of drugs for COVID-19 proved drug repurposing is a vital strategy in medical science for the upcoming years. Springer US 2022-12-07 2022 /pmc/articles/PMC9734433/ /pubmed/36531825 http://dx.doi.org/10.1007/s11094-022-02778-w Text en © Springer Science+Business Media, LLC, part of Springer Nature 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Rao, Nutan Poojari, Tushar Poojary, Charvi Sande, Ruksar Sawant, Sonal Drug Repurposing: a Shortcut to New Biological Entities |
title | Drug Repurposing: a Shortcut to New Biological Entities |
title_full | Drug Repurposing: a Shortcut to New Biological Entities |
title_fullStr | Drug Repurposing: a Shortcut to New Biological Entities |
title_full_unstemmed | Drug Repurposing: a Shortcut to New Biological Entities |
title_short | Drug Repurposing: a Shortcut to New Biological Entities |
title_sort | drug repurposing: a shortcut to new biological entities |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734433/ https://www.ncbi.nlm.nih.gov/pubmed/36531825 http://dx.doi.org/10.1007/s11094-022-02778-w |
work_keys_str_mv | AT raonutan drugrepurposingashortcuttonewbiologicalentities AT poojaritushar drugrepurposingashortcuttonewbiologicalentities AT poojarycharvi drugrepurposingashortcuttonewbiologicalentities AT sanderuksar drugrepurposingashortcuttonewbiologicalentities AT sawantsonal drugrepurposingashortcuttonewbiologicalentities |